cysteine has been researched along with Chagas Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Freitag-Pohl, S; Murillo, AM; Pohl, E; Silber, AM; Sowerby, K | 1 |
| Bottazzi, ME; Brown, EL; Essigmann, HT; Gunter, SM; Hotez, PJ; Jones, KM; Seid, CA; Strych, U; Zhan, B | 1 |
| Garg, NJ; Wiktorowicz, JE; Zago, MP | 1 |
| Batthyány, C; Buschiazzo, A; Demicheli, V; Durán, R; Hugo, M; Larrieux, N; Lima, A; Martí, MA; Martinez, A; Moreno, DM; Peluffo, G; Petruk, AA; Piacenza, L; Piñeyro, D; Radi, R; Robello, C; Trujillo, M | 1 |
| Bottazzi, ME; Gutierrez, A; Hammond, M; Hotez, PJ; Hudspeth, E; Jones, KM; Keegan, B; Liu, Z; McAtee, CP; Pollet, J; Respress, JL; Seid, CA; Strych, U; Versteeg, L; Wei, J; Zhan, B | 1 |
| Nicoll-Griffith, DA | 1 |
| Becker, I; Berzunza, M; Cabrera, N; de Gómez-Puyou, MT; García, J; Gómez-Puyou, A; López-Calahorra, F; Olivares-Illana, V; Pérez-Montfort, R; Rodríguez-Romero, A | 1 |
| Chabé, F; Gomez-Corvera, R; Guevara-Espinoza, A; Ouaissi, A; Taibi, A | 1 |
1 review(s) available for cysteine and Chagas Disease
| Article | Year |
|---|---|
Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease.
Topics: Animals; Biphenyl Compounds; Catalytic Domain; Cathepsin K; Chagas Disease; Cysteine; Cysteine Endopeptidases; Cysteine Proteases; Cysteine Proteinase Inhibitors; Dipeptides; Dogs; Drug Discovery; Humans; Leishmaniasis; Mice; Phenylalanine; Piperazines; Prodrugs; Protein Binding; Protozoan Proteins; Tosyl Compounds; Trypanocidal Agents; Trypanosoma; Trypanosomiasis, African; Vinyl Compounds | 2012 |
7 other study(ies) available for cysteine and Chagas Disease
| Article | Year |
|---|---|
Cysteine synthase: multiple structures of a key enzyme in cysteine synthesis and a potential drug target for Chagas disease and leishmaniasis.
Topics: Animals; Cattle; Chagas Disease; Cysteine; Cysteine Synthase; Leishmaniasis; Trypanosoma cruzi | 2023 |
Mutations to Cysteine Residues in the Trypanosoma cruzi B-Cell Superantigen Tc24 Diminish Susceptibility to IgM-Mediated Hydrolysis.
Topics: Animals; Antibodies, Protozoan; B-Lymphocytes; Calcium-Binding Proteins; Chagas Disease; Cysteine; Hydrolysis; Immunity, Innate; Immunization; Immunoglobulin M; Mice; Mutation; Protein Isoforms; Protozoan Vaccines; Sequence Alignment; Serine; Superantigens; Trypanosoma cruzi | 2017 |
Fluorescence Proteomic Technology to Analyze Peripheral Blood Mononuclear Cells in Chronic Chagas Disease.
Topics: Biomarkers; Chagas Disease; Chronic Disease; Cysteine; Electrophoresis, Gel, Two-Dimensional; Fluorescence; Humans; Leukocytes, Mononuclear; Mass Spectrometry; Nitric Oxide; Proteins; Proteomics | 2019 |
Structural and molecular basis of the peroxynitrite-mediated nitration and inactivation of Trypanosoma cruzi iron-superoxide dismutases (Fe-SODs) A and B: disparate susceptibilities due to the repair of Tyr35 radical by Cys83 in Fe-SODB through intramolec
Topics: Animals; Binding Sites; Blotting, Western; Catalytic Domain; Chagas Disease; Crystallography, X-Ray; Cysteine; Electron Spin Resonance Spectroscopy; Electron Transport; Enzyme Activation; Host-Parasite Interactions; Isoenzymes; Kinetics; Models, Molecular; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Nitrates; Peroxynitrous Acid; Protein Binding; Protein Structure, Secondary; Protozoan Proteins; Reactive Oxygen Species; Superoxide Dismutase; Trypanosoma cruzi; Tyrosine | 2014 |
Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Chagas Disease; Cysteine; Disease Models, Animal; Female; Heart; Interferon-gamma; Leukocytes, Mononuclear; Mice, Inbred BALB C; Mutagenesis; Parasite Load; Protozoan Proteins; Protozoan Vaccines; Recombinant Proteins; Survival Analysis; Trypanosoma cruzi; Vaccines, Synthetic | 2017 |
Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi.
Topics: Aniline Compounds; Animals; Chagas Disease; Cysteine; Dimerization; Escherichia coli; Humans; Incidence; Kinetics; Models, Molecular; Protein Conformation; Recombinant Proteins; Sequence Deletion; Triose-Phosphate Isomerase; Trypanosoma cruzi; X-Ray Diffraction | 2007 |
A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione.
Topics: Animals; Cells, Cultured; Chagas Disease; Cysteine; Glutathione; Humans; Immune Tolerance; Mice; Mice, Inbred BALB C; Protozoan Proteins; Spleen; T-Lymphocytes; Thymidine; Trypanosoma cruzi | 1995 |